| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +60.00% | +3.54% | -0.58% | +4.12% | +1.61% | — |
| 14d | 5 | +40.00% | +2.30% | +0.15% | +2.15% | +6.64% | — |
| 30d | 5 | +40.00% | +2.27% | -0.02% | +2.29% | +3.02% | — |
| 60d | 5 | +80.00% | -1.79% | -3.85% | +2.06% | +0.21% | — |
| 90d | 5 | +40.00% | -2.79% | +0.42% | -3.21% | +4.25% | — |
| 180d | 5(2 pending) | +100.00% | -16.46% | +3.90% | -20.36% | -25.87% | — |
| 1y | 5(4 pending) | +0.00% | +3.48% | +15.38% | -11.91% | -11.91% | — |
| 2y | 5(5 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KURA KURA ONCOLOGY, INC. | SALE10b5-1 10b5-1 plan | 10,000 | $11.00 | $110.0K | 173,614 | May 21, 2026 | May 22, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE10b5-1 10b5-1 plan | 339 | $9.21 | $3.1K | 183,614 | May 19, 2026 | May 20, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Commercial Officer | 4,842 | $8.46 | $41.0K | 184,847 | Jan 27, 2026 | Jan 27, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Commercial Officer | 1,572 | $8.46 | $13.3K | 183,275 | Jan 27, 2026 | Jan 27, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 189,689 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Commercial Officer | 8,887 | $11.18 | $99.3K | 139,689 | Nov 14, 2025 | Nov 14, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 48,900 | — | — | 148,576 | Nov 13, 2025 | Nov 14, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Commercial Officer | 8,891 | $8.94 | $79.5K | 99,676 | Sep 29, 2025 | Sep 29, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 48,900 | — | — | 108,567 | Sep 27, 2025 | Sep 29, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Commercial Officer | 1,583 | $7.87 | $12.5K | 59,667 | Jan 28, 2025 | Jan 28, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 46,250 | — | — | 61,250 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 92,500 | — | — | 92,500 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Aug 14, 2023 | Aug 16, 2023 ↗ | View → |
| FATE FATE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 425,000 | — | — | 425,000 | Feb 6, 2023 | Feb 7, 2023 ↗ | View → |
| FATE FATE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 45,000 | — | — | 45,000 | Jun 27, 2022 | Jun 29, 2022 ↗ | View → |
| FATE FATE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Jun 27, 2022 | Jun 29, 2022 ↗ | View → |